The role of desensitization of glucocorticoid receptors in the development of vascular resistance to endogenous vasoconstrictors in traumatic shock

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 6, 2007, Pages 3-8

  Kozhevnikova, L M ^a   Avdonin, P P ^a   Sukhanova, I F ^a   Avdonin, P V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547650983     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Baker C. H., Sutton E. T., Zhou Z., Reynolds D. G. Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock. Circ. Shock 1990; 32 (2): 101-112.
2. Fieber D., Horina G., Sandner-Kiesling A. et al. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats. Cardiovasc. Res. 1999; 44 (1): 166-175.
3. Bucher M., Hobbhahn J., Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit. Care Med. 2001; 29 (9): 1750-1755.
4. Bucher M., Hobbhahn J., Taeger K., Kurtz A. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 282 (4): 979-984.
5. Hamu Y., Kanmura Y., Tsuneyoshi I., Yoshimura N. The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. Anesth. Analg. 1999; 88 (3): 542-548.
6. Liu L. M., Ward J. A., Dubick M. A. Hemorrhage-induced vascular hyporeactivity to norepinephrine in select vasculatures of rats and the roles of nitric oxide and endothelin. Shock 2003; 19 (3): 208-214.
7. Armstead V. E., MinchenkoA. G., Scalla R., Lefer A. M. Pulmonary tissue factor mRNA expression during murine traumatic shock: effect of P-selectin blockade. Shock 2001; 15 (4): 323-326.
8. Adembri C., Kastamoniti E., Bertolozzi I. et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit. Care Med. 2004; 32 (5): 1170-1177.
9. Schneider C. P., Schwacha M. G., Chaudry I. H. The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim. Biophys. Acta 2004; 1689 (1): 22-32.
10. Muldoon S. M., McKensie J. E., Collins F. J. Pressor effect of nalbuphine in hemorrhagic shock is dependent on the sympathoadrenal system. Circ. Shock 1988; 26 (1): 89-98.
11. Baker C. H., Sutton E. T., Zhou Z., Reynolds D. G. Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock. Circ. Shock 1990; 32 (2): 101-112.
12. Russian source
13. Russian source
14. Kifor I., Dzau V. J. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ. Res. 1987; 60 (3): 422-428.
15. Murasawa S., Matsubara H., Kizima K. et al. Glucocorticoids regulate Via vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cells. Hypertension 1995; 26 (4): 665-669.
16. Watters J. J., Swank M. W., Wilkinson C. W., Dorsa D. M. Evidence for glucocorticoid regulation of the rat vasopressin Via receptor gene. Peptides 1996; 17 (1): 67-73.
17. Wissink S., Meijer O., Pearce D. et al. Regulation of the rat serotonin-IA receptor gene by corticosteroids. J. Biol. Chem. 2000; 275 (2): 1321-1326.
18. Zhang X., Krishnamoorthy R. R., Prasanna G. et al. Dexamethasone regulates endothelin-1 and endothelin receptors in human non-pigmented ciliary epithelial (HNPE) cells. Exp. Eye Res. 2003; 76 (3): 261-272.
19. Bryant C. E., Perretti M., Flower R. J. Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: a possible role for lipocortin 1. Biochem. Pharmacol. 1998; 55 (3): 279-285.
20. Russian source
21. Russian source
22. Sonin N. V., Garcia-Pagan J. C., Nakanishi K. et al. Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock 1999; 11 (3): 175-179.
23. Ishimaru S., Shichiri M., Mineshita S., Hirata Y. Role of endothelin-1/endothelin receptor system in endotoxic shock rats. Hypertens. Res. 2001; 24 (2): 119-126.
24. Hirata Y., Ishimaru S. Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model. Clin. Sci. 2002; 103 (48): 332-335.
25. Rensing H., Bauer I., Zhang J. X. et al. Endothelin-1 and heme oxygenase-1 as modulators of sinusoidal tone in the stress-exposed rat liver. Hepatology 2002; 36 (6): 1453-1465.
26. Ferguson S. S., Menard L., Barak L. S. et al. Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1. J. Biol. Chem. 1995; 270 (42): 24782-24789.
27. Freedman N. J., Liggett S. B., Drachman D. E. et al. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J. Biol. Chem. 1995; 270 (30): 17953-17961.
28. Kirigiti P., Bai Y., Yang Y. F. et al. Agonist-mediated down-regulation of rat beta 1-adrenergic receptor transcripts: role of potential post-transcriptional degradation factors. Mol. Pharmacol. 2001; 60 (6): 1308-1324.
29. Russian source
30. Uno S., Guo D. F., Nakajima M. et al. Glucocorticoid induction of rat angiotensin II type IA receptor gene promoter. Biochem. Biophys. Res. Commun. 1994; 204 (1): 210-215.
31. Nickenig G., Harrison D. G. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation. Circulation 2002; 105 (4): 530-536.
32. Petrovic N., Kane C. M., Sigmund C. D., Gross K. W. Downregulation of renin gene expression by interleukin-1. Hypertension 1997; 30 (2): 230-235.
33. Caffrey J. L., Hathorne L. F., Carter G. C., Sinclair R. J. Naloxone potentiates contractile responses to epinephrine in isolated canine arteries. Circ. Shock 1990; 31 (3): 317-332.
34. Chang S. L., Felix B., Jiang Y., Fiala M. Actions of endotoxin and morphine. Adv. Exp. Med. Biol. 2001; 493: 187-196.
35. Carmignani M., Zucchetti F., Sacco R. et al. Shock induction by arterial hypoperfusion of the gut involves synergistic interactions between the peripheral enkephalin and nitric oxide systems. Int. J. Immunopathol. Pharmacol. 2005; 18 (1): 33-48.
36. Kai L., Wang Z. F., Shi Y. L. et al. Opioid receptor antagonists increase [Ca2+]i in rat arterial smooth muscle cells in hemorrhagic shock. Acta Pharmacol. Sin. 2004; 25 (3): 395-400.
37. Borcsok I., Schairer H. U., Sommer U. et al. Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene. J. Exp. Med. 1998; 188 (9): 1563-1573.
38. Bamberger C. M., Schulte H. M., Chrousos G. P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 1996; 17 (3): 245-261.
39. Burnstein K. L., Bellingham D. L., Jewell C. M. et al. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991; 56 (2): 52-58.
40. Silva C. M., Powell-Oliver F. E., Jewell C. M. et al. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994; 59 (7): 436-442.
41. Burnstein K. L., Jewell C. M., Cidlowski J. A. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J. Biol. Chem. 1990; 265 (13): 7284-7291.
42. Nobukuni Y., Smith C. L., Hager G. L., Detera-Wadleigh S. D. Characterization of the human glucocorticoid receptor promoter. Biochemistry 1995; 34 (25): 8207-8214.
43. Vig E., Barrett T. J., Vedeckis W. V. Coordinate regulation of glucocorticoid receptor and c-jun mRNA levels: evidence for cross-talk between two signaling pathways' at the transcriptional level. Mol. Endocrinol. 1994; 8 (10): 1336-1346.
44. Glusa E., Pertz H. H. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors. Br. J. Pharmacol. 2000; 130 (3): 692-698.
45. Datte J. Y., Offoumou M. A. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle. J. Pharm. Pharmaceut. Sci. 2004; 7 (1): 1-7.
46. Jahnichen S., Radtke O. A., Pertz H. H. Involvement of 5-HT1B receptors in triiptan-induced contractile responses in guinea-pig isolated iliac artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 2004; 370 (1): 54-63.
47. Watts S. W. Activation of the mitogen-activated protein kinase pathway via the 5-HT2A receptor. Ann. N. Y. Acad. Sci. 1998; 861: 162-168.
48. Kato S., Kumamoto H., Hirano M. et al. Expression of 5-HT2A and 5-HT1B receptor mRNA in blood vessels. Mol. Cell. Biochem. 1999; 199 (1-2): 57-61.
49. Banes A. K., Watts S. W. Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension. BMC Pharmacol. 2003; 3: 12.